Literature DB >> 27638358

Unravelling mucosal immunity to poliovirus.

Edward P K Parker1, Nicholas C Grassly2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27638358     DOI： 10.1016/S1473-3099(16)30371-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania.

Authors:  Ananda S Bandyopadhyay; Chris Gast; Elizabeth B Brickley; Ricardo Rüttimann; Ralf Clemens; M Steven Oberste; William C Weldon; Margaret E Ackerman; Ruth I Connor; Wendy F Wieland-Alter; Peter Wright; Vytautas Usonis
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226

2.  Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules.

Authors:  Ananda S Bandyopadhyay; Edwin J Asturias; Miguel O'Ryan; M Steven Oberste; William Weldon; Ralf Clemens; Ricardo Rüttimann; John F Modlin; Chris Gast
Journal:  Vaccine       Date:  2017-11-14       Impact factor: 3.641

Review 3.  Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.

Authors:  Ananda S Bandyopadhyay; John F Modlin; Jay Wenger; Chris Gast
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

Review 4.  Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication.

Authors:  Kimberly M Thompson; Dominika A Kalkowska
Journal:  Expert Rev Vaccines       Date:  2020-08-01       Impact factor: 5.217
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.